Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Initiation
  • Large Cap
  • Markets
  • News
  • Price Target

This Analyst Is Bullish On Entegris As A Value Compounder With Strong Growth Prospects: Initiates With Outperform Rating

By Lekha Gupta
June 20, 1:57 PM
BMO Capital Markets analyst Bhavesh Lodaya initiated coverage of Entegris Inc (NASDAQ: ENTG) at an 

ENTG

Read More
2 minute read
  • Dividends
  • General
  • Large Cap
  • Long Ideas
  • News
  • Tech
  • Trading Ideas

How To Earn $500 A Month From AT&T Stock

By AJ Fabino
June 20, 1:50 PM
AT&T Inc. (NYSE:T) CFO Pascal Desroches spoke Tuesday at the Bank of America C-Suite Technology, Media and Telecommunications…

BAC

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Novo Nordisk Takes Legal Action Against Wellness Clinics for False Advertising of Weight Loss Drug

By Vandana Singh
June 20, 1:49 PM
Novo Nordisk A/S (NYSE: NVO) has filed lawsuits against several medical spas, weight-loss clinics, and wellness clinics, alleging they illegally marketed custom-made versions of Ozempic and other Novo Nordisk medicines for weight loss. 

NVO

Read More
2 minute read
  • Broad U.S. Equity ETFs
  • ETFs
  • General
  • Large Cap
  • Markets
  • Mid Cap
  • News
  • Tech
  • Topics
  • Trading Ideas

43 Stocks That Will Never Sleep With Robinhood’s 24-Hour Trading: What You Need To Know

By AJ Fabino
June 20, 1:02 PM
Robinhood Markets Inc (NASDAQ:HOOD) is rolling out 24-hour trading, 5 days a week, in an effort to appeal…

COIN

Read More
1 minute read
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • News

Kraft Heinz Expects Long-Term Organic Sales Growth Of 2%-3%

By Lekha Gupta
June 20, 12:07 PM
The Kraft Heinz Co (NASDAQ: KHC) announced its 

KHC

Read More
1 minute read
  • Equities
  • Large Cap
  • Markets
  • News

Raytheon’s Pratt & Whitney Plans $206M Investment In Columbus, Georgia Business

By Lekha Gupta
June 20, 11:57 AM
Raytheon Technologies Corp's (NYSE: RTX) Pratt & Whitney disclosed the investment of $206 million to 

RTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Merck Says Keytruda Regimen Fails To Improve Event-Free Survival In Gastric Cancer Patients

By Vandana Singh
June 20, 11:00 AM
Merck & Co Inc (NYSE: MRK) announced topline results from the Phase 3 KEYNOTE-585 trial of Keytruda (pembrolizumab) in combination with chemotherapy as a 

MRK

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Eli Lilly To Acquire Small Company DICE Therapeutics Focused On Autoimmune Diseases For $2B

By Vandana Singh
June 20, 9:51 AM
Eli Lilly And Co (NYSE: LLY) has agreed to acquire DICE Therapeutics Inc (NASDAQ: DICE), a biopharmaceutical company that leverages its proprietary DELSCAPE technology platform to develop oral therapeutic ca

DICE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Novo Nordisk Faces Delayed Obesity Drug Wegovy Launch In New Markets Amid Surging Demand

By Vandana Singh
June 20, 8:44 AM
Danish pharmaceutical company Novo Nordisk A/S (NYSE: NVO) announced that introducing its obesity drug Wegovy in most European countries will experience delays, and the drug is not expected to be available in developing nations for an extended period. 

NVO

Read More
1 minute read
  • Asset Sales
  • Equities
  • Large Cap
  • Markets
  • News

Nasdaq Transfers Its European Power Business To EEX For Undisclosed Sum

By Lekha Gupta
June 20, 8:28 AM
Nasdaq Inc (NASDAQ: NDAQ) inked an agreement with the European Energy Exchange (EEX) to transfer its European power trading and 

NDAQ

Posts pagination

Previous 1 … 287 288 289 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service